Abivax SA

ABVX · Healthcare

$113.67

Markedsværdi: 9.92B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Abivax SA? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire1. sep. 2026, 11.00

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

Simply Wall St.26. jul. 2026, 08.07

ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In?

GlobeNewswire30. jul. 2026, 20.05

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod

MT Newswires24. jul. 2026, 09.47

Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating

Business Wire4. aug. 2026, 07.00

Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer